Evidence map›Paper›PMID 40929136›Full record

ArticleBioinformatics (Oxford, England)2025

TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model.

Yang An, Valter Bergant, Samuele Firmani, Corinna Grünke, Batiste Bonnal, Alexander Henrici, Andreas Pichlmair, Benjamin Schubert, Annalisa Marsico

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Protein Language Models in Virology: A Review of Advances and Applications.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang AnComputational Health Center, Helmholtz Center Munich, Neuherberg 85764, Germany.ORCID 0000-0003-1225-3534
Valter BergantInstitute of Virology, Technical University of Munich, Munich 80333, Germany.ORCID 0000-0003-3458-9506
Samuele FirmaniComputational Health Center, Helmholtz Center Munich, Neuherberg 85764, Germany.
Corinna GrünkeInstitute of Virology, Technical University of Munich, Munich 80333, Germany.
Batiste BonnalInstitute of Virology, Technical University of Munich, Munich 80333, Germany.
Alexander HenriciInstitute of Virology, Technical University of Munich, Munich 80333, Germany.
Andreas PichlmairInstitute of Virology, Technical University of Munich, Munich 80333, Germany.ORCID 0000-0002-0166-1367
Benjamin SchubertComputational Health Center, Helmholtz Center Munich, Neuherberg 85764, Germany.ORCID 0000-0003-3412-1102
Annalisa MarsicoComputational Health Center, Helmholtz Center Munich, Neuherberg 85764, Germany.

Funding

BMBF Clusters4FutureCenter for Immunology of Viral Infections (CiViA)CNATMDanish National Research Foundation 164Helmholtz AssociationHelmholtz Association's Initiative and Networking Fund KA1-Co-02Helmholtz International Lab Causal Cell DynamicsSlovenian Research and Innovation Agency J4-60082Slovenian Research and Innovation Agency P1-0242the German Research Foundation TRR179/TP10the German Research Foundation TRR237/A07the German Research Foundation TRR353/B04
6 · The paper itself

Abstract

motivationRecent pandemics have revealed significant gaps in our understanding of viral pathogenesis, exposing an urgent need for methods to identify and prioritize key host proteins (host factors) as potential targets for antiviral treatments. De novo generation of experimental datasets is limited by their heterogeneity, and for looming future pandemics, may not be feasible due to limitations of experimental approaches.

resultsHere, we present TransFactor, a computational framework for predicting and prioritizing candidate host factors using only protein sequence data. It leverages the pre-trained ESM-2 protein language model, fine-tuned on a limited set of experimentally determined host factors aggregated from 33 independent SARS-CoV-2 studies. TransFactor outperforms machine and deep learning baselines and its predictions align with Gene Ontology enrichments of known host factors, but also provide interpretability through a computational alanine scan, enabling the identification of pro-viral protein domains such as COMM, PX, and RRM, that may be used to direct experimental investigations of virus biology and guide rational design of antiviral therapies. Our findings demonstrate the potential of transformer-based models to advance host factor prediction, providing a framework extendable to orthogonal input modalities and other infectious diseases, enhancing our preparedness for current and future viral threats. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/marsico-lab/TransFactor. A full reproducibility package, including code, trained models, and data, is archived on Zenodo (https://doi.org/10.5281/zenodo.16793684).

Indexed as

Computational BiologyCOVID-19Host-Pathogen InteractionsSARS-CoV-2Viral ProteinsDeep LearningHumansSoftwareViral Proteins

Identifiers

PMID40929136
PMCPMC12449051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.